Prevalence and awareness of CKD among African Americans: the Jackson Heart Study

Michael F Flessner1, Sharon B Wyatt, Ermeg L Akylbekova

  • 1Department of Medicine, University of Mississippi Medical Center, Jackson, MS 39216-4505, USA. mflessner@medicine.umsmed.edu

Insights

Chronic kidney disease (CKD) affects 20% of African Americans in the Jackson Heart Study, with low awareness (15.8%). Early diagnosis and education are crucial for managing this growing epidemic.

Area of Science:

  • Nephrology
  • Public Health
  • Epidemiology

Background:

  • Chronic kidney disease (CKD) is a global health concern, disproportionately affecting African Americans with a fourfold higher incidence of end-stage renal disease compared to whites in the U.S.
  • Understanding CKD prevalence and awareness within specific populations is critical for targeted public health interventions.

Purpose of the Study:

  • To examine the prevalence and awareness of chronic kidney disease (CKD) among African Americans participating in the Jackson Heart Study (JHS).
  • To identify demographic, socioeconomic, and clinical factors associated with CKD prevalence and awareness in this cohort.

Main Methods:

  • An observational cohort study utilizing data from the Jackson Heart Study (JHS).
  • CKD was defined by estimated glomerular filtration rate (<60 mL/min/1.73 m2), albuminuria, or dialysis. Data included medical history, anthropometrics, and serum/urine samples.
  • Logistic regression models assessed associations between CKD and various parameters, including demographic, socioeconomic, healthcare access, and disease status.

Main Results:

  • The JHS cohort exhibited a 20% prevalence of CKD, with only 15.8% awareness among participants.
  • Older age was associated with higher CKD prevalence and greater awareness. Factors like hypertension, diabetes, cardiovascular disease, and hypertriglyceridemia were linked to increased CKD prevalence.
  • Only advanced CKD stage correlated with increased awareness, highlighting a gap in early disease recognition.

Conclusions:

  • The Jackson Heart Study reveals a significant burden of CKD with low awareness, particularly in individuals with less advanced disease.
  • There is an urgent need for earlier CKD diagnosis and enhanced educational initiatives for both healthcare providers and the general population to combat this epidemic.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...